BY6-24858-24483 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-11-22
Dose 1 — Pfizer-BioNTech
2021-12-13
Dose 2 — Pfizer-BioNTech
2021-12-18
Registered in v-safe
2021-12-18
Health check-in — days 1–6 daily, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-20
Health check-in — day 7, dose 2, dependent
Feeling: Good · None

Adult check-in
2021-12-27
Survey response — day 14, dose 2, dependent
MedDRA: Cough, Rhinorrhoea — Feeling: Good

Free text: Cough, rhinorrhea No fever, no dyspnea

MedDRA releases: 2024-11 · check-in free text available
2022-01-03
Health check-in — day 21, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-10
Health check-in — day 28, dose 2, dependent
Feeling: Good

Adult check-in
2022-01-19
Health check-in — day 35, dose 2, dependent
Feeling: Good

Adult check-in
2022-06-14
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-12-15
Health check-in — 12 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-11-22	Pfizer-BioNTech	No
2	2021-12-13	Pfizer-BioNTech	No

Free text

Release 10 — day 14, dose 2, dependent

2021-12-27

Symptoms: Cough, rhinorrhea No fever, no dyspnea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release